ArticleJournal of molecular medicine (Berlin, Germany)2018

Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.

Ting-Ting Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.